Climb Bio (CLYM) Earnings Date & Reports

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CLYM is expected to report earnings to fall 41.94% to -18 cents per share on August 19

Q2'25

Est.

$-0.18

Q1'25

Missed

by $0.16

The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -15 cents. With 145.78K shares outstanding, the current market capitalization sits at 97.98M.

View a ticker or compare two or three

Compare

CLYM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CLYM
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details